Functional Diversity of Compartmentalized Calcium Signaling in Airway Smooth Muscle

气道平滑肌区室化钙信号传导的功能多样性

基本信息

  • 批准号:
    10062409
  • 负责人:
  • 金额:
    $ 54.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-12-15 至 2023-11-30
  • 项目状态:
    已结题

项目摘要

Project Summary In the proposed studies we seek to disentangle the complex effects of intracellular calcium in the regulation of airway smooth muscle (ASM) contraction. Although biochemical events mediating the effects of calcium on cross-bridge cycling and contraction have been understood and accepted for years, what remains mystifying is how the ASM cell compartmentalizes calcium to regulate the contractile machinery. Our recent findings demonstrate that conventional and simplistic assessments of intracellular calcium signaling have no predictive ability regarding regulation of smooth muscle contractile state. In recent publications we demonstrate the seemingly paradoxical ability of elevated intracellular calcium to mediate relaxation of ASM when stimulated by agonists of bitter taste receptors (TAS2Rs) whereas almost all other G protein-coupled receptors (GPCRs) capable of inducing increased intracellular calcium mediate contraction. Similarly, ligands such as natural flavonoids, chloride channel antagonists, GABAA agonists cause acute ASM relaxation despite causing an acute transient [Ca2+]i increase. Clearly, the disparate effects by GPCRs on ASM contractile state reflect the long-appreciated but poorly-understood ability of the cell to compartmentalize calcium signaling. The relaxant effect of calcium signaling, if understood, could be exploited therapeutically for the management of the airway hyperresponsiveness. To achieve our goal we will combine expertise and strategies in 5 major areas: GPCR biology, biophysics of calcium, cell imaging, proteomics and mathematical modeling. Aim 1 studies will define the mechanisms involved in spatial and temporal distribution of calcium signaling in ASM induced by different GPCR agonists. We will define and localize all proteins, structural elements, and enzymatic activities that regulate calcium distribution in ASM cells stimulated with different GPCR agonists. We will test how disruption of these regulatory elements alters the features of intracellular calcium and the associated regulation of ASM tone. In aim 2 studies, we will employ hyperspectral imaging and phosphoproteomics tools to discern GPCR- specific activation of effector proteins in ASM. With these data we will develop descriptive and predictive mathematical models (Aim 3) that define the key regulatory features enabling compartmentalized calcium signaling and predict the functional consequences of such signaling. The computational models will be validated using experimental data obtained through studies using primary human airway smooth muscle cells and tissues. Our success banks on the unique ability of our team to creatively apply and coordinate cutting edge imaging approaches, multi-fluorophore hyperspectral image analysis, and modeling to well-defined experimental systems that demonstrate disparate and unexplained functional consequences of intracellular calcium. The findings will not only advance the basic science fields of receptor biology and calcium signaling, but also identify targets whose manipulation could be exploited for developing novel bronchodilator therapies.
项目摘要 在拟议的研究中,我们试图解开细胞内钙在调节中的复杂作用。 气道平滑肌(ASM)收缩。尽管生物化学事件介导了钙对人体健康的影响 跨桥自行车和收缩运动多年来一直被人们理解和接受,但令人费解的是 ASM细胞如何划分钙以调节收缩机械。我们最新的发现 证明对细胞内钙信号的常规和简单化评估没有预测性 对平滑肌收缩状态的调节能力。在最近的出版物中,我们展示了 刺激时细胞内钙升高似乎自相矛盾地调节ASM的松弛 苦味受体激动剂(TAS2Rs)而几乎所有其他G蛋白偶联受体(GPCRs) 能够诱导细胞内钙离子介导的收缩增加。同样,天然等配体 黄酮类,氯通道拮抗剂,GABAA激动剂引起急性ASM松弛,尽管引起 急性暂时性[Ca~(2+)]i升高。显然,GPCRs对ASM收缩状态的不同影响反映了 长期以来,人们对细胞划分钙信号的能力赞不绝口,但知之甚少。松弛药 如果了解钙信号的作用,可以将其用于治疗呼吸道管理。 高反应性。为了实现我们的目标,我们将结合5个主要领域的专业知识和战略: 生物学、钙的生物物理学、细胞成像、蛋白质组学和数学建模。目标1研究将定义 不同浓度的钙离子在ASM中的时空分布机制 GPCR型激动剂。我们将定义和定位所有蛋白质、结构元素和酶活性 调节不同GPCR激动剂刺激的ASM细胞内钙的分布。我们将测试如何颠覆 这些调控元件改变了细胞内钙的特性以及与ASM相关的调控 语气。在Aim 2研究中,我们将使用高光谱成像和磷酸蛋白质组学工具来识别gpr- ASM中效应蛋白的特异性激活。有了这些数据,我们将制定描述性和预测性 数学模型(目标3),定义了允许区分钙的主要监管特征 并预测这种信令的功能后果。计算模型将是 通过使用原代人呼吸道平滑肌细胞的研究获得的实验数据进行验证 还有纸巾。我们的成功有赖于我们团队创造性地应用和协调切割的独特能力 边缘成像方法、多荧光团高光谱图像分析和清晰定义的建模 演示细胞内不同且无法解释的功能后果的实验系统 钙。这些发现不仅将推进受体生物学和钙信号的基础科学领域, 而且还确定了可以利用其操纵来开发新的支气管扩张剂疗法的靶点。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Apoptosis signal-regulating kinase 1 inhibition attenuates human airway smooth muscle growth and migration in chronic obstructive pulmonary disease.
  • DOI:
    10.1042/cs20180398
  • 发表时间:
    2018-07-31
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Eapen MS;Kota A;Vindin H;McAlinden KD;Xenaki D;Oliver BG;Deshpande DA;Sohal SS;Sharma P
  • 通讯作者:
    Sharma P
MicroRNA-638 inhibits human airway smooth muscle cell proliferation and migration through targeting cyclin D1 and NOR1.
  • DOI:
    10.1002/jcp.26930
  • 发表时间:
    2018-01
  • 期刊:
  • 影响因子:
    5.6
  • 作者:
    Wang H;Yao H;Yi B;Kazama K;Liu Y;Deshpande D;Zhang J;Sun J
  • 通讯作者:
    Sun J
Therapeutic potential and challenges of bitter taste receptors on lung cells.
  • DOI:
    10.1016/j.coph.2020.07.004
  • 发表时间:
    2020-04
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Conaway S Jr;Nayak AP;Deshpande DA
  • 通讯作者:
    Deshpande DA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Deepak A Deshpande其他文献

Deepak A Deshpande的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Deepak A Deshpande', 18)}}的其他基金

Optimizing function-selective ERK1/2 inhibitors for reducing AP-1-mediated airway pathology in asthma.
优化功能选择性 ERK1/2 抑制剂以减少 AP-1 介导的哮喘气道病理。
  • 批准号:
    10666887
  • 财政年份:
    2023
  • 资助金额:
    $ 54.18万
  • 项目类别:
tRNA-derived non-coding RNAs in ASM function and in asthma
tRNA 衍生的非编码 RNA 在 ASM 功能和哮喘中的作用
  • 批准号:
    10434062
  • 财政年份:
    2020
  • 资助金额:
    $ 54.18万
  • 项目类别:
tRNA-derived non-coding RNAs in ASM function and in asthma
tRNA 衍生的非编码 RNA 在 ASM 功能和哮喘中的作用
  • 批准号:
    10643968
  • 财政年份:
    2020
  • 资助金额:
    $ 54.18万
  • 项目类别:
Diacylglycerol kinase in airway smooth muscle functions
二酰甘油激酶在气道平滑肌功能中的作用
  • 批准号:
    10204427
  • 财政年份:
    2019
  • 资助金额:
    $ 54.18万
  • 项目类别:
Diacylglycerol kinase in airway smooth muscle functions
二酰甘油激酶在气道平滑肌功能中的作用
  • 批准号:
    10090626
  • 财政年份:
    2019
  • 资助金额:
    $ 54.18万
  • 项目类别:
Diacylglycerol kinase in airway smooth muscle functions
二酰甘油激酶在气道平滑肌功能中的作用
  • 批准号:
    10588000
  • 财政年份:
    2019
  • 资助金额:
    $ 54.18万
  • 项目类别:
Diacylglycerol kinase in airway smooth muscle functions
二酰甘油激酶在气道平滑肌功能中的作用
  • 批准号:
    10349442
  • 财政年份:
    2019
  • 资助金额:
    $ 54.18万
  • 项目类别:
Diacylglycerol kinase in airway smooth muscle functions
二酰甘油激酶在气道平滑肌功能中的作用
  • 批准号:
    9898459
  • 财政年份:
    2019
  • 资助金额:
    $ 54.18万
  • 项目类别:
Functional Diversity of Compartmentalized Calcium Signaling in Airway Smooth Muscle
气道平滑肌区室化钙信号传导的功能多样性
  • 批准号:
    9901263
  • 财政年份:
    2017
  • 资助金额:
    $ 54.18万
  • 项目类别:
Evaluation of novel substrate specific inhibitors of ERK1/2 in the treatment of asthma
新型ERK1/2底物特异性抑制剂治疗哮喘的评价
  • 批准号:
    9293245
  • 财政年份:
    2016
  • 资助金额:
    $ 54.18万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了